Title: Carlton Bradley Brown: Innovator in Peptide Formulations Introduction Carlton Bradley Brown is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of peptide-based therapies. His innovative work focuses on creating formulations that enhance the efficacy of peptide drugs. Latest Patents Carlton Bradley Brown holds a patent for a groundbreaking invention titled "Fluorocarbon-Linked Peptide Formulation." This invention provides an aqueous acidic formulation suitable for use in the preparation of a pharmaceutically acceptable fluorocarbon-linked peptide formulation. The formulation comprises a first fluorocarbon-linked peptide that is at least 20 amino acid residues long, contains at least 50% hydrophobic amino acid residues, and has an isoelectric point greater than or equal to 7. Additionally, the fluorocarbon-linked peptide is present in micelles. Career Highlights Carlton is currently employed at Altimmune UK Limited, where he continues to advance his research in peptide formulations. His work is pivotal in the development of new therapeutic options for various medical conditions. Despite having no patents listed under his name, his contributions to the field are noteworthy. Collaborations Carlton has collaborated with esteemed colleagues such as Bertrand Victor Georges and Jean Francois Thaburet. These partnerships have fostered a collaborative environment that enhances innovation and research in peptide formulations. Conclusion Carlton Bradley Brown is a dedicated inventor whose work in peptide formulations has the potential to impact the pharmaceutical industry significantly. His innovative approach to creating effective drug formulations showcases his commitment to advancing medical science.

Growing community of inventors

GB

Carlton Bradley Brown